Medical Weight Management
We are CQC registered as a medical setting for the treatment of Obesity and Overweight. This means that you are in the safest, experienced hands when visiting us.
We are able to offer you a Medical Weight Management Service with prescription medication to suppress your appetite. Mounjaro and Wegovy are medications that have been approved for weight loss and weight management in the UK by the Medicines and Health Products Regulation Agency (MHRA).
You will receive guidance and support throughout your weight loss journey from our team of Medical Professionals.
Overweight and Obesity are associated with an increased risk of developing some cancers, cardiovascular disease and type 2 diabetes. Starting your weight loss journey will have numerous benefits to your health.
What are Mounjaro and Wegovy?
Mounjaro and Wegovy are both injectable medications that can help to regulate your appetite, reduce cravings and leave you feeling fuller for longer.
Both medications involve a once weekly injection administered at home by yourself. We will guide you through this process and teach you how to safely administer your medication.
Mounjaro and Wegovy are clinically proven to help overweight individuals to achieve sustained weight loss when used alongside a reduced calorie diet, increased physical activity and when making healthier lifestyle choices.
How do they work?
Wegovy uses the active ingredient, semaglutide (a glucagon-like peptide-1 or GLP-1 for short) which is a hormone that is naturally present in your body that helps to regulate appetite. GLP-1 helps to reduce the amount of sugar produced in the liver, boost basal insulin and decrease appetite.
The active ingredient in Mounjaro is called Tirzepatide. Tirzepatide works on two different hormone receptors. GLP-1 (as with Wegovy) but also Glucose-dependent insulinotropic polypeptide (GIP). GIP regulates energy balance in brain and fat cells, enhancing the GLP-1 effect of suppressing your appetite and improving sugar control.
By mimicking the effect of both naturally occuring hormones, Mounjaro has been shown to have greater weight loss potential than medicines that work on GLP-1 alone.
Weight loss results are promising, with clinical trials showing that at 72 weeks of consistent Tirzepatide use, the average weight loss was 22.5%.
Various doses of Wegovy and Mounjaro are available with patients starting on a lower dose and gradually increasing each month as needed.
Who can have Mounjaro or Wegovy?
Mounjaro and Wegovy are available to patients with a body mass index (BMI) of 30 or over. Or a BMI of 27 and over, where additional health conditions related to body weight, such as high blood pressure, are present.
If you are interested to find out more about Weight Loss Injections but aren’t sure if you fit the criteria, please make an initial enquiry with our team of health care professionals by clicking below to complete an online assessment form. We will contact you shortly after to confirm your eligibility and, if suitable, to arrange an appointment at the clinic.
Pricing and Next Steps:
Medical Weight Management starts at £200.00 for your initial assessment and first month’s medication.
Please see our Price List for monthly costs thereafter.
Prior to booking an appointment, please click the link below to complete an online assessment form. We will then be in touch with you shortly after to confirm your suitability for treatment.
Our team are looking forward to welcoming you to the clinic soon.
